Novartis Pharmaceuticals Corporation
Part of Novartis
CompanySwitzerlandFounded 1996
Novartis Pharmaceuticals Corporation develops 69 assets, the furthest approved (Afinitor in advanced breast cancer). Mostly small molecule and antibody acting on PIK3CA, IL17A and PIK3CD; based in Switzerland, founded in 1996.
- 69
- Assets
- Furthest stage
- Approved
- 1,361
- Trials
- 275
- Signals
Pipeline
69Approved, Small molecule, FKBP1A, advanced breast cancer, breast neoplasm
Fixed-dose combination of renin inhibitor aliskiren and calcium channel blocker amlodipine.
Approved, not sold in the US, Small molecule, hypertension (Phase 3), cardiovascular events (Phase 3)
Combination of direct renin inhibitor and angiotensin II type 1 receptor antagonist reducing blood pressure.
Approved, not sold in the US, Small molecule, hypertension (Phase 3), stage 2 hypertension (Phase 3)
66 more assets
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms9
- Trials1,675
- Deals1
- Signals20
- Integrity notices1
- Similar companies6
Papers
Circulation. Population health and outcomes, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
bioRxiv, Nov 7, 2026
Frontiers in cardiovascular medicine, Jul 30, 2026
Plasma GDF15 affects long-term dementia risk and alters neuroimmune signaling
Science advances, Jun 27, 2026
Journal of the American Society of Nephrology : JASN, Mar 29, 2026
Journal of the American Heart Association, Mar 18, 2026
Journal of clinical lipidology, Mar 8, 2026
Inclisiran in Patients with CKD: Post Hoc Pooled Analysis of Three Phase 3 Trials
Journal of the American Society of Nephrology : JASN, Jan 28, 2026
JACC. Advances, Jan 22, 2026
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension: A Randomized Phase 2 Trial
Journal of the American College of Cardiology, Jan 21, 2026
AHA Scientific Sessions 2025 abstract, Nov 3, 2025
MON-005 AN UNUSUAL CASE OF VASOMOTOR SYMPTOMS IN A POST-MENOPAUSAL WOMAN
ENDO 2025 abstract, Oct 23, 2025
Effects of Acute Late Isocaloric Eating on 24-h Blood Glycemia in Adults with Overweight and Obesity
ADA Scientific Sessions 2025 abstract, Jun 13, 2025
The therapeutic potential of exercise for improving mobility in multiple sclerosis
Frontiers in physiology, Sep 13, 2024
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
Journal of the American College of Cardiology, Sep 2, 2022